Sign In Register

The Atopic Dermatitis Channel

RADLA 2026 Atopic dermatitis in adults: diagnosis, misdiagnosis, and therapeutic approaches

Atopic Dermatitis

Atopic dermatitis in adults: diagnosis, misdiagnosis, and therapeutic approaches at RADLA 2026 | Date: May 19, 2026 | Time: 4-5:30 PM ART |Buenos Aires City Convention Center, Av. Figueroa Alcorta 2099, Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina | Room D

Featured Videos in Atopic Dermatitis

How State Data Reveal Gaps in Atopic Dermatitis Care Access Thumbnail

How State Data Reveal Gaps in Atopic Dermatitis Care Access

Atopic Dermatitis

Don’t Be Rash: Balancing Topical Steroids in the Era of Nonsteroidals Thumbnail

Don’t Be Rash: Balancing Topical Steroids in the Era of Nonsteroidals

Atopic Dermatitis

Exosome Progress and Remibrutinib Label Expansion Thumbnail

Exosome Progress and Remibrutinib Label Expansion

Atopic Dermatitis

More in Atopic Dermatitis

See All

How State Data Reveal Gaps in Atopic Dermatitis Care Access Thumbnail

How State Data Reveal Gaps in Atopic Dermatitis Care Access

Atopic Dermatitis

Psoriasis and HS Pipeline Outlook 2027 With Douglas DiRuggiero, PA-C Thumbnail

Psoriasis and HS Pipeline Outlook 2027 With Douglas DiRuggiero, PA-C

Atopic Dermatitis

Don’t Be Rash: Balancing Topical Steroids in the Era of Nonsteroidals Thumbnail

Don’t Be Rash: Balancing Topical Steroids in the Era of Nonsteroidals

Atopic Dermatitis

Why Medicare Patients Still Miss Out on Advanced Derm Therapy Thumbnail

Why Medicare Patients Still Miss Out on Advanced Derm Therapy

Atopic Dermatitis

3-Year Nemolizumab Data in Atopic Dermatitis, With Sarina Elmariah, MD, PhD Thumbnail

3-Year Nemolizumab Data in Atopic Dermatitis, With Sarina Elmariah, MD, PhD

Atopic Dermatitis

Exosome Progress and Remibrutinib Label Expansion Thumbnail

Exosome Progress and Remibrutinib Label Expansion

Atopic Dermatitis